[ Price : $8.95]
Cubist Pharmaceuticals initiates a Phase 3 clinical study of CB-5945 in patients with opioid-induced constipation.[ Price : $8.95]
Federal Register Notice: FDA amends a notice of a 11/29 meeting of the Cellular, Tissue and Gene Therapies Advisory Committee to m...[ Price : $8.95]
A bill being floated on Capitol Hill to establish a nationwide drug tracking system allows tracking at the lot level and not at th...[ Price : $8.95]
FDA grants approval for GI Dynamics to initiate a clinical trial of EndoBarrier for treating patients who have uncontrolled Type 2...[ Price : $8.95]
Neuraltus says it is planning a Phase 3 trial of its NP001 in patients with Lou Gehrigs disease.[ Price : $8.95]
FDA approves the first of four PMA modules submitted by Cohera Medical for its TissuGlu Surgical Adhesive product.[ Price : $8.95]
FDA accepts for review two applications from Sunovion for expanded indications for its schizophrenia drug Latuda.[ Price : $8.95]
FDAs Minneapolis District Office warns Ortho Molecular Products that it is selling unapproved new drugs that are mislabeled.